Cargando…

COVID-19 can present with a rash and be mistaken for dengue

Detalles Bibliográficos
Autores principales:	Joob, Beuy, Wiwanitkit, Viroj
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	by the American Academy of Dermatology, Inc. 2020
Materias:	JAAD Online
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7156802/ https://www.ncbi.nlm.nih.gov/pubmed/32213305 http://dx.doi.org/10.1016/j.jaad.2020.03.036

Ejemplares similares

Reply to: “Various forms of skin rash in COVID-19: Petechial rash in a patient with COVID-19 infection”
por: Joob, Beuy, et al.
Publicado: (2020)

Caution in the time of rashes and COVID-19
por: Vesely, Matthew D., et al.
Publicado: (2020)

Algorithm for the classification of COVID-19 rashes
por: Ortega-Quijano, Daniel, et al.
Publicado: (2020)

Comment on “Androgenetic alopecia present in the majority of patients hospitalized with COVID-19”
por: Bukovac, Domen, et al.
Publicado: (2021)

Reply to: “Comment on ‘Androgenetic alopecia present in the majority of patients hospitalized with COVID-19’”
por: Wambier, Carlos G.
Publicado: (2021)

Can hydroxychloroquine be useful in the prevention of COVID-19? An Italian survey in dermatologic and rheumatologic patients already under treatment
por: Vastarella, Maria, et al.
Publicado: (2020)

Comment on “The impact of the COVID-19 pandemic on the presentation status of newly diagnosed melanoma: A single institution experience”
por: McFeely, Orla, et al.
Publicado: (2021)

Reply to “COVID-19 can present with a rash and be mistaken for dengue”: Petechial rash in a patient with COVID-19 infection
por: Jimenez-Cauhe, Juan, et al.
Publicado: (2020)

COVID-19 and racial disparities
por: Shah, Monica, et al.
Publicado: (2020)

Does hydroxychloroquine combat COVID-19? A timeline of evidence
por: Alia, Erisa, et al.
Publicado: (2020)

Androgenetic alopecia in COVID-19: Compared to what?
por: Nanes, Benjamin A.
Publicado: (2020)

COVID-19 and immunomodulator/immunosuppressant use in dermatology
por: Price, Kyla N., et al.
Publicado: (2020)

Male balding is a major risk factor for severe COVID-19
por: Lee, Justin, et al.
Publicado: (2020)

Reply to: “A dermatologic manifestation of COVID-19: Transient livedo reticularis”
por: Thomas, Cristina
Publicado: (2020)

Hydroxychloroquine and ivermectin: A synergistic combination for COVID-19 chemoprophylaxis and treatment?
por: Patrì, Angela, et al.
Publicado: (2020)

Toward a COVID-19 vaccine strategy for patients with pemphigus on rituximab
por: Waldman, Reid A., et al.
Publicado: (2021)

Comment on “Psoriasis and COVID-19: A bidirectional Mendelian randomization study”
por: Gu, Xiaoyu, et al.
Publicado: (2023)

Could antiphospholipid antibodies contribute to coagulopathy in COVID-19?
por: Parodi, Aurora, et al.
Publicado: (2020)

Experience in patients with hidradenitis suppurativa and COVID-19 symptoms
por: Galán, José Luis, et al.
Publicado: (2020)

Expansion of asynchronous teledermatology during the COVID-19 pandemic
por: Su, Mack Y., et al.
Publicado: (2020)

Optimal time for the resumption of biologics after COVID-19
por: Kow, Chia Siang, et al.
Publicado: (2020)

Reply to: “Biologics for psoriasis during COVID-19 outbreak”
por: Murrell, Dedee F., et al.
Publicado: (2020)

Recommendations on dermatologic surgery during the COVID-19 pandemic
por: Der Sarkissian, Samuel Antranig, et al.
Publicado: (2020)

COVID-19 compels closer scrutiny of disparities in dermatology
por: Temiz, Laurie A., et al.
Publicado: (2021)

#DermTwitter and digital mentorship in the COVID-19 era
por: Zheng, David X., et al.
Publicado: (2021)

The COVID-19 crisis: A unique opportunity to expand dermatology to underserved populations
por: Ashrafzadeh, Sepideh, et al.
Publicado: (2020)

Reply to: “Reply: A dermatologic manifestation of COVID-19: Transient livedo reticularis”
por: Manalo, Iviensan F., et al.
Publicado: (2020)

Response to comment on “Psoriasis and COVID-19: A bidirectional Mendelian randomization study”
por: Chalitsios, Christos V., et al.
Publicado: (2023)

A response to “Male balding is a major risk factor for severe COVID-19”
por: Thatiparthi, Akshitha, et al.
Publicado: (2021)

Optimizing education for dermatology residents during the COVID-19 pandemic
por: Patel, Parth, et al.
Publicado: (2020)

Telemedicine for inpatient dermatology consultations in response to the COVID-19 pandemic
por: Trinidad, John, et al.
Publicado: (2020)

COVID-19 and its effect on medical student education in dermatology
por: Loh, Tiffany Y., et al.
Publicado: (2020)

Proposed approach for reusing surgical masks in COVID-19 pandemic
por: Liu, Yuangang, et al.
Publicado: (2020)

Reply: Potential role of Janus kinase inhibitors in COVID-19
por: Napolitano, Maddalena, et al.
Publicado: (2020)

Treatment considerations for patients with pemphigus during the COVID-19 pandemic
por: Shakshouk, Hadir, et al.
Publicado: (2020)

Modifications to dermatology residency education during the COVID-19 pandemic
por: Mufti, Asfandyar, et al.
Publicado: (2020)

COVID-19: Should sexual practices be discouraged during the pandemic?
por: Yin, ZhiQiang
Publicado: (2020)

Response to: “Applying to dermatology residency during the COVID-19 pandemic”
por: Alia, Erisa, et al.
Publicado: (2021)

Successful implementation of phototherapy guidelines during the COVID-19 pandemic
por: Dragan, Emma, et al.
Publicado: (2021)

Expanding teledermatology educational opportunities after the COVID-19 pandemic
por: Hassan, Shahzeb, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_oja5ni5pa2pfphco265gsfmdj5